Home » Topics » Disease categories and therapies » Urology

Urology
RSS

ErepoXen increases hemoglobin levels to therapeutic range in phase II trial

July 16, 2015

Merck & Co. divulges ROMK channel blockers

July 15, 2015

Aquinox Pharmaceuticals reports data from LEADERSHIP trial

June 26, 2015

Eppin Pharma receives NIH grant to develop non-hormonal male contraceptive

June 19, 2015

Angion Biomedica to begin phase II trial of BB3 in acute kidney injury

June 10, 2015

Regulus Therapeutics starts phase I trial of Alport syndrome candidate RG-012

June 5, 2015

Galenica to commercialize Roche's Mircera in U.S.

May 29, 2015

Jinarc approved in Europe for autosomal dominant polycystic kidney disease

May 28, 2015

ZS Pharma seeks U.S. approval of ZS-9 for hyperkalemia

May 27, 2015

Daiichi Sankyo develops phosphate transporter inhibitors

May 22, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...